Observational study on the prevalence and risk factors of patients with hyperkalaemia in Brazil - HOPE

Study identifier:D9480R00075

ClinicalTrials.gov identifier:NCT07370194

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

Investigating the Impact of Serum Potassium Levels on Prevalence and Risk Factors Associated with Management Strategies for Patients with Hyperkalaemia in Brazilian Clinical Settings: An Observational Study.

Medical condition

Hyperkalemia

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

6215

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 28 Feb 2026
Estimated Primary Completion Date: 30 Sept 2026
Estimated Study Completion Date: 30 Sept 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2026 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria